Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15906875 | 0.75 | MEN1 (0.31) | KMT2AALDH1A1 | |
| SCHEMBL4887030 | 0.74 | ALDH1A1 (0.54) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| SCHEMBL4887039 | 0.74 | ALDH1A1 (0.54) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL6119092 | 0.72 | ALDH1A1 (0.51) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL7180535 | 0.72 | ALDH1A1 (0.51) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL7175502 | 0.72 | ALDH1A1 (0.51) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL7175999 | 0.72 | ALDH1A1 (0.51) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL7173330 | 0.72 | ALDH1A1 (0.51) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL7183213 | 0.72 | ALDH1A1 (0.51) | KMT2ADUSP3PTPN11ALDH1A1ALOX15 | |
| SCHEMBL15840503 | 0.68 | ALDH1A1 (0.41) | KMT2AALDH1A1ALOX15NPC1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | APALENE TECHNOLOGY CO., LTD. (HANGZHOU) (CN) | 2019-10-15 | — | — | US | disclosed |
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | APALENE TECHNOLOGY CO., LTD. (JIAXING) (CN) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180147571-A1 | NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF | UBE2L3, RNF168, AGL | KMT2A 3932/4885DUSP3 4835/4885PTPN11 4780/4885 |
| US-10441946-B2 | Linear alpha-olefin catalysts and preparation and use thereof | UBE2L3, COG8, ACSL3 | KMT2A 3907/4885DUSP3 4808/4885PTPN11 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.